paragon (PGN) - Accelerating progress

17:16 EDT 22 Aug 2018 | Edison Investment Research

Edison Investment Research - General Industrials - paragon: paragon continues to make strong progress, with Q218 showing a clear acceleration that should enable increased group FY18 revenue guidance to be met. Voltabox is making strategic investments to augment organic growth, through the adjustment to the Triathlon supply contract and the purchase of Navitas. Although the former does not impact operational profitability, it does incur a financial cost that has led to a €2m reduction in current year EBIT. We have adjusted our earnings estimates to reflect this, but we have yet to consolidate Navitas as the deal is not completed.
ISIN: DE0005558696

Original Article: paragon (PGN) - Accelerating progress


More From BioPortfolio on "paragon (PGN) - Accelerating progress"

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...